Pirouz Daftarian has over 20 yrs of experience in academia, biopharma, and CRO in immuno-oncology and vaccines. He completed his Ph.D. and postdoctoral at U of Ottawa, UBC, and the City of Hope. He then joined IMV a vaccine company, and led the pre-clinical immuno-oncology as the Head cancer biologist. He then joined U. Miami's Miller School of Medicine as an assistant. Professor and the Director of Biological Modifiers Core Facility, (2007-2015). He then NGM Biopharmaceutical and then JSRLS., before U of Miami. He has over 90 peer-reviewed papers, and acted as a reviewer of DOD, NIH, NCI, and several journals.